Guilhem Tourniaire, PhD

Founder and Managing Director
Cellenion SASU, France

Poster(s):

• (W1174) INNOVATIVE WORKFLOW FOR DRUG RESPONSE STUDIES ON SINGLE 3D CELL MODELS COMBINING SPHEROONE and INCUCYTE.
  Wednesday, June 11, 2025

  5:00 PM - 6:00 PM HK Time